Rashmi Dongerdiye

Rashmi Dongerdiye

Auto-generated profile, based on publicly available information

Rashmi Dongerdiye

Department of Haematogenetics, ICMR-National Institute of Immunohematology, Indian Council of Medical Research, Mumbai, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2019 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
PKPrabhakar Kedar
Prabhakar Kedar
HHHideo Harigae
Hideo Harigae
EIEtsuro Ito
Etsuro Ito
HMHideki Muramatsu
Hideki Muramatsu
SKSeiji Kojima
Seiji Kojima
MMManisha Madkaikar
Manisha Madkaikar

9 March 2023 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
RDRashmi Dongerdiye
Rashmi Dongerdiye
MBMeghana Bokde
Meghana Bokde
TMTejashree Anil More
Tejashree Anil More
ASArati Saptarshi
Arati Saptarshi
RDRati Devendra
Rati Devendra
PKPrabhakar Kedar
Prabhakar Kedar

27 October 2021 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
ASAbhilasha Sampagar
Abhilasha Sampagar
MGManasi Gosavi
Manasi Gosavi
PKPrabhakar Kedar
Prabhakar Kedar
TPTaiseenub Patel
Taiseenub Patel
RDRashmi Dongerdiye
Rashmi Dongerdiye
NMNiranjana Mahantashetti
Niranjana Mahantashetti


28 August 2024 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
RDRashmi Dongerdiye
Rashmi Dongerdiye
PKPrabhakar Kedar
Prabhakar Kedar
ASArati Saptarshi
Arati Saptarshi
ASAbhilasha Sampagar
Abhilasha Sampagar
CSChandrakala Shanmukhaiah
Chandrakala Shanmukhaiah
MMManisha Madkaikar
Manisha Madkaikar

16 July 2023 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ASArati Nandan Saptarshi
Arati Nandan Saptarshi
RDRashmi K. Dongerdiye
Rashmi K. Dongerdiye
TMTejashree Anil More
Tejashree Anil More
PKPrabhakar Kedar
Prabhakar Kedar
Background: Congenital dyserythropoietic anemias (CDAs) are a very rare and heterogeneous group of disorders characterized by ineffective erythropoiesis. CDA II is caused by mutations in the SEC23B gene. The most common mutation reported in India is c.1385 A > G, p.Y462C. There is no simple and cost-effective confirmatory diagnostic test available for CDA, and therefore, many patients remain undiagnosed. High-resolution melting curve (HRM) analysis is a polymerase chain reaction (PCR) based technique applied to identify genetic differences and scan nucleic acid sequences. HRM can be used to rapidly screen the common mutation causing CDA II in the Indian population. Thus, we studied the use of High-Resolution Melting Curve Analysis to detect common mutation causing CDA II in the Indian population. Method: 11 patients having SEC23B (Y462C) mutation causing CDA II are considered for this study. HRM was used to check the presence of Y462C mutation. To verify the accuracy of the HRM analysis, we compared HRM results with the results of Sanger sequencing. This helped us to confirm the diagnosis. Results: We have described the clinical, hematological, and genetic data of eleven patients suffering from CDAII. According to HRM and Sanger sequencing, a homozygous SEC23B (Y462C) mutation was present in all patients, whereas a heterozygous Y462C mutation was present in their parents. Conclusion: Our data showed that High-Resolution Melting (HRM) analysis could be used to rapidly screen common SEC23B mutation that causes CDA II in the Indian population.